Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

VBC Biemans, C.J. van der Woude, G Dijkstra, AEE de Jong, M Lowenberg, NK de Boer, B Oldenburg, N Srivastava, J Jansen, AG Bodelier, rachel West, Annemarie de Vries, JJL Haans, D Jong, F Hoentjen, MJ Pierik

Research output: Contribution to journalArticleAcademicpeer-review

99 Citations (Scopus)
18 Downloads (Pure)
Original languageEnglish
Pages (from-to)123-134
Number of pages12
JournalAlimentary Pharmacology & Therapeutics
Issue number1
Publication statusPublished - 2020

Research programs

  • EMC MM-04-20-01

Cite this